Both type I and III IFN are known to induce tumour apoptosis, enhance antigen processing and presentation in tumours, facilitate the production of pro-inflammatory cytokines in DCs and inhibition of Tregs [9, 62, 63], thus promoting immune cell-mediated killing of tumour cells. This evidence concerns the gene IFNA1 and neoplasm.